MedTrace Logo

BPIT 5-Week Multi-Site Study: Movement Efficiency, Mobility & Neuromuscular Adaptation

NCT07256717 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 369

Last updated 2025-12-16

No results posted yet for this study

Summary

This prospective, multi-site, single-arm interventional study evaluates the 5-Line Principle of Balanced Progressive Intensity Training (BPIT) over 5 weeks in healthy adults aged 18-65 years. All participants receive supervised BPIT sessions (3-5 per week) progressing through five intensity lines defined by anatomical landmarks and ground reaction force:

Ground-Based (Low) Knee-Level (Low-Moderate) Standing (Moderate) Head-Level (Moderate-High) Plyometric (High-Impact)

The study aims to quantify improvements in functional movement efficiency, joint mobility, postural control, strength adaptation, and heart-rate variability while monitoring safety and individual overload indicators.

Conditions

  • Physical Fitness

Interventions

BEHAVIORAL

Balanced Progressive Intensity Training (BPIT) 5-Line Method

5-week supervised progressive training using the BPIT 5-Line framework developed by Dr. Neeraj Mehta.

Sponsors & Collaborators

  • BodyGNTX Fitness Institute

    collaborator UNKNOWN

  • GFFI Fitness Academy

    collaborator UNKNOWN

  • Indian Institute of Kinesiology and Biomechanics Science (IIKBS)

    collaborator UNKNOWN

  • Bureau of Fitness Standards (BFS)

    collaborator UNKNOWN

  • Active India Health & Fitness Trust (AIHFT)

    collaborator UNKNOWN

  • Body Mechanic Chain of Gyms

    collaborator UNKNOWN

  • Shri Mahaveer Ortho Clinic

    collaborator UNKNOWN

  • Regain Fitness Zone

    collaborator UNKNOWN

  • MMSx Authority Biomechanics Department

    collaborator UNKNOWN

  • MMSx Authority Institute for Movement Mechanics & Biomechanics Research Inc.

    lead OTHER

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-10-10
Primary Completion
2026-02-15
Completion
2026-02-25

Countries

  • United States
  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07256717 on ClinicalTrials.gov